Advertisement

Lipids and Lipid-Lowering Drugs and Graft Function

  • H. Drexel
  • F. W. Amann

Abstract

There is a relationship between the type of graft changes and the time since operation. (a) Thrombotic events are almost exclusively responsible for early graft closures and account for an attrition rate of 10% by 1 month after operation [16]. (b) By the end of the first postoperative year a further 10% loss of patent bypasses has occurred because of intimal fibromuscular hypertrophy. (c) Atherosclerotic plaque, in contrast, is not detectable prior to the end of the first year after operation and is rarely observed before the end of the second or third year [1, 2, 23, 30-32]. Plaques are observed histologically in 21% of grafts at a mean of 5 years after operation; about one-third of grafts at this time have more than 75% atherosclerotic obstructions, and a further one-third have total occlusions secondary to atherosclerosis. In one study, atherosclerosis — defined as intimal foam cell accumulation or frank plaques — was found only 39 or more months after operation and was present in 79% of such cases [29]. Consistent with the temporal sequence of graft changes, all atherosclerotic grafts show some degree of intimal fibromuscular proliferation.

Keywords

Cholesteryl Ester Cholesteryl Ester Transfer Protein Internal Mammary Artery Saphenous Vein Graft Hepatic Lipase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Atkinson JB, Forman MB, Perry JM (1985) Correlation of saphenous vein bypass graft angiograms with histologic changes at necropsy. Am J Cardiol 55: 952–955.PubMedCrossRefGoogle Scholar
  2. 2.
    Atkinson JB, Forman MB, Vaughn WK (1985) Morphologic changes in long-term saphenous vein bypass grafts. Chest 88: 341–348.PubMedCrossRefGoogle Scholar
  3. 3.
    Blankenhorn DH, Kramsch DM (1989) Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation 79: 1–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L (1987) Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 257: 3233–3240.CrossRefGoogle Scholar
  5. 5.
    Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP (1990) Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81: 470–476.PubMedCrossRefGoogle Scholar
  6. 6.
    Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Selzer RH, Shircore AM, Wickham EC (1991) Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation 83: 438–447.PubMedGoogle Scholar
  7. 7.
    Blankenhorn DH, Selzer RH, Mack WJ, Crawford DW, Pagoda J, Lee PJ, Shircore AM, Azen SP (1992) Evaluation of colestipol/niacin therapy with computer-derived coronary end-point measures. A comparison of different measures of treatment effect. Circulation 86: 1701–1709.PubMedGoogle Scholar
  8. 8.
    Bonchek LI, Boerboom LE, Olinger GN (1982) Prevention of lipid accumulation in experimental vein bypass grafts by anti-platelet therapy. Circulation 66: 338–341.PubMedCrossRefGoogle Scholar
  9. 9.
    Bourassa MG, Enjalbert M, Campeau L (1984) Progression of atherosclerosis in coronary arteries and bypass grafts. Ten years later. Am J Cardiol 53: 102C–107C.PubMedCrossRefGoogle Scholar
  10. 10.
    Bourassa MG, Fisher LD, Campeau L (1985) Long-term fate of bypass grafts. The Coronary Artery Surgery Study and Montreal Heart Institute experiences. Circulation 72: V–71–V–78.Google Scholar
  11. 11.
    Bourassa MG, Campeau L, Lesperance J (1991) Changes in grafts and in coronary arteries after coronary bypass surgery. In: Waters DD, Bourassa MG (eds) Care of the patient with previous coronary bypass surgery. Cardiovascular clinics 21/2. Davis, Philadelphia, pp 83–100.Google Scholar
  12. 12.
    Campeau L, Enjalbert M, Lesperance J (1983) Atherosclerosis and late closure of aortocoronary saphenous vein grafts. Sequential angiographie studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 68: 11–1–11–7.Google Scholar
  13. 13.
    Campeau L, Enjalbert M, Lesperance J (1984) The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 311: 1329–1332.PubMedCrossRefGoogle Scholar
  14. 14.
    Cameron A, Kemp HG Jr, Green GE (1986) Bypass surgery with the internal mammary artery graft 15 year follow-up. Circulation 74: 111–30–111–36.Google Scholar
  15. 15.
    Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH (1990) Beneficial effects of colestipol-niacin on coronary atherosclerosis. J Am Med Assoc 264: 3013–3017.CrossRefGoogle Scholar
  16. 16.
    European Coronary Surgery Study Group (1982) Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 2: 1173–1180.Google Scholar
  17. 17.
    Friedman M (1963) Spontaneous atherosclerosis and experimental thromboatherosclerosis. Arch Pathol 76: 571–577.PubMedGoogle Scholar
  18. 18.
    Grondin CM, Campeau L, Lesperance J (1979) Atherosclerotic changes in coronary vein grafts six years after operation. Angiographie aspect in 110 patients. J Thorac Cardiovasc Surg 77: 24–31.PubMedGoogle Scholar
  19. 19.
    Grondin CM, Campeau L, Lesperance J (1984) Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 70: 208–212.Google Scholar
  20. 20.
    Harper LA, Ross R, Slichter SJ (1976) Homocystine-induced atherosclerosis. J Clin Invest 58: 731–741.CrossRefGoogle Scholar
  21. 21.
    Havel RJ, Kane JP (1989) Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) Metabolic basis of inherited disease. McGraw-Hill, New York, pp 1129–1138.Google Scholar
  22. 22.
    King P, Royle JP (1972) Autogenous vein grafting in atheromatous rabbits. Cardiovasc Res 6: 627–633.PubMedCrossRefGoogle Scholar
  23. 23.
    Lie JT, Lawrie GM, Morris GC Jr (1977) Aortocoronary bypass saphenous vein graft artherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 40: 906–914.PubMedCrossRefGoogle Scholar
  24. 24.
    Loop FD, Lytle BW, Cosgrove DM (1986) Influence of the internal mammary-artery graft on 10 year survival and other cardiac events. N Engl J Med 314: 1–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Roberts WC (1989) Lipid-lowering therapy after an atherosclerotic event (editorial). Am J Cardiol 64: 693–695.PubMedCrossRefGoogle Scholar
  26. 26.
    Rossiter SJ, Brody WR, Kosek JC, Liptom MJ, Angell WW (1974) Internal mammary artery versus autogenous vein for coronary artery bypass graft. Circulation 50: 1236–1243.PubMedGoogle Scholar
  27. 27.
    Sako Y (1961) Susceptibility of autologous vein grafts to atheromatous degeneration. Surg Forum 12: 247–249.PubMedGoogle Scholar
  28. 28.
    Scott HW Jr, Morgan CV, Bolasny BL, Lainer VC, Younger RK, Butts W (1970) Experimental atherosclerosis in autogenous venous grafts. Arch Surg 101: 677–682.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith SH, Geer JC (1983) Morphology of saphenous vein coronary artery bypass grafts. Arch Pathol Lab Med 107: 13–18.PubMedGoogle Scholar
  30. 30.
    Solymoss BC, Nadeau P, Millette D (1988) Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 78: 1–140-1-143.CrossRefGoogle Scholar
  31. 31.
    Spray TL, Roberts WC (1977) Status of the grafts and the native coronary arteries proximal and distal to coronary anastomotic sites of aortacoronary bypass grafts. Circulation 55: 741–749.PubMedGoogle Scholar
  32. 32.
    Vlodaver Z, Edwards JE (1973) Pathologic analysis in fatal cases following saphenous vein coronary arterial bypass. Chest 64: 555–563.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • H. Drexel
  • F. W. Amann

There are no affiliations available

Personalised recommendations